JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) saw a large increase in short interest in July. As of July 31st, there was short interest totaling 13,260 shares, an increase of 596.1% from the July 15th total of 1,905 shares. Based on an average trading volume of 2,556 shares, the days-to-cover ratio is currently 5.2 days. Approximately 0.2% of the shares of the company are short sold.
Institutional Investors Weigh In On JLens 500 Jewish Advocacy U.S. ETF
A number of institutional investors have recently modified their holdings of the business. JPMorgan Chase & Co. acquired a new stake in JLens 500 Jewish Advocacy U.S. ETF during the third quarter worth about $25,000. Bank of New York Mellon Corp boosted its stake in JLens 500 Jewish Advocacy U.S. ETF by 66.7% in the first quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock valued at $1,946,000 after acquiring an additional 28,496 shares during the period. Finally, Captrust Financial Advisors bought a new position in shares of JLens 500 Jewish Advocacy U.S. ETF during the second quarter valued at approximately $6,038,000.
JLens 500 Jewish Advocacy U.S. ETF Stock Performance
TOV remained flat at $32.47 during trading hours on Wednesday. The company had a trading volume of 720 shares, compared to its average volume of 11,172. The stock has a 50 day simple moving average of $31.51 and a 200-day simple moving average of $30.06. JLens 500 Jewish Advocacy U.S. ETF has a 52-week low of $26.52 and a 52-week high of $32.72. The firm has a market capitalization of $272.75 million, a PE ratio of 25.69 and a beta of 1.03.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
See Also
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- Hims & Hers’ Revenue Beat Came With a Profitability Problem
- A Westinghouse IPO Could Reset the Nuclear Stock Conversation
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
- Paramount’s 30-Film Promise Puts AMC Back in the Box Office Conversation
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
